FrancophonIA/ELRC3.0 huggingface dataset:
English: • dizziness, tingling feelings like pins and needles or electric shock-like feelings (particularly in the head), sleep disturbances (vivid dreams, nightmares, inability to sleep), fatigue, sleepiness, feeling restless or agitated, feeling anxious, feeling sick (nausea) or being sick (vomiting), shaking (tremor), headaches, muscle pain, feeling irritable, diarrhoea, excessive sweating or vertigo.
Croatian: • omaglica, trnci ili osjeti nalik strujnom udaru (osobito u glavi), smetnje spavanja (živopisni snovi, noćne more, nemogućnost spavanja), umor, pospanost, nemir ili uznemirenost, tjeskoba, mučnina ili povraćanje, nevoljno drhtanje (tremor), glavobolja, bol u mišićima, razdražljivost,
English: If you forget to take Duloxetine Lilly
Croatian: Ako ste zaboravili uzeti Duloksetin Lilly
English: Thoughts of suicide and worsening of your depression or anxiety disorder If you are depressed and/or have anxiety disorders you can sometimes have thoughts of harming or killing yourself.
Croatian: Ako ste depresivni i/ili imate anksiozni poremećaj, ponekad Vam se mogu javiti misli o samoozljeđivanju ili samoubojstvu.
English: After an oral dose the apparent plasma clearance of duloxetine ranges from 33 to 261 l/hr (mean 101 l/hr).
Croatian: Prividni klirens duloksetina iz plazme nakon peroralno primijenjene doze kreće se u rasponu od 33 do 261 l/h (srednja vrijednost 101 l/h).
English: Table 1: Adverse reactions
Croatian: Tablica 1: Nuspojave
English: Hypertension3,7 Orthostatic hypotension2
Croatian: crvenilo uz osjećaj vrućine sinkopa2 hipertenzija3,7 ortostatska hipotenzija2
English: Sleep disorder Bruxism Disorientation Apathy
Croatian: poremećaj spavanja bruksizam dezorijentacija apatija suicidalno ponašanje5,7
English: The 30 mg capsules are blue and white and are printed with ‘30 mg' and the code ‘9543'.
Croatian: Kapsule od 30 mg su plave i bijele boje s otisnutim oznakom „30 mg“ i oznakom „9543“.
English: The effect of Duloxetine Lilly 60 mg once a day in elderly depressed patients (≥65 years) was specifically examined in a study that showed a statistically significant difference in the reduction of the HAMD17 score for duloxetine-treated patients compared to placebo.
Croatian: Učinak lijeka Duloksetin Lilly u dozi od 60 mg jednom dnevno u starijih depresivnih bolesnika (≥ 65 godina) posebno je ispitivan u ispitivanju koje je pokazalo statistički značajnu razliku u smanjenju broja bodova na HAMD17 ljestvici u bolesnika liječenih duloksetinom u odnosu na one koji su uzimali placebo.
English: • suicidal thoughts, difficulty sleeping, grinding or clenching the teeth, feeling disorientated, lack of motivation
Croatian: • samoubilačke misli, tegobe sa spavanjem, škripanje ili stiskanje zubima, dezorijentiranost,
English: OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
Croatian: OD LIJEKA, AKO JE POTREBNO
English: In patients with uncontrolled hypertension duloxetine should not be initiated (see section 4.3).
Croatian: Ne smije se započeti liječenje duloksetinom u bolesnika s nekontroliranom hipertenzijom (vidjeti dio 4.3).
English: You must wait at least 14 days after you have stopped taking an MAOI before you can take Duloxetine Lilly.
Croatian: Nakon što ste prestali uzimati inhibitor MAO, morate pričekati najmanje 14 dana prije nego počnete uzimati Duloksetin Lilly.
English: The efficacy of Duloxetine Lilly 30-120 mg (flexible dosing) once a day in elderly patients (>65 years) with generalised anxiety disorder was evaluated in a study that demonstrated statistically significant improvement in the HAM-A total score for duloxetine treated patients compared to placebo treated patients.
Croatian: Djelotvornost lijeka Duloksetin Lilly u dozi od 30-120 mg (fleksibilno doziranje) jednom dnevno u starijih bolesnika (> 65 godina) s generaliziranim anksioznim poremećajem ocijenjena je u ispitivanju koje je pokazalo statistički značajno poboljšanje ukupnog broja bodova na HAM-A ljestvici u bolesnika liječenih duloksetinom u odnosu na one koji su uzimali placebo.
English: Edible white ink: titanium dioxide (E171), propylene glycol, shellac, povidone.
Croatian: Jestiva bijela tinta: titanijev dioksid (E171), propilenglikol, šelak, povidon.
English: The starting and recommended maintenance dose is 60 mg once daily with or without food.
Croatian: Početna doza i preporučena doza održavanja je 60 mg jednom dnevno, a uzima se s hranom ili bez nje.
English: Two patients who transitioned from placebo to duloxetine after the acute phase experienced suicidal behaviours while taking duloxetine during the extension phase.
Croatian: U dva bolesnika koja su nakon akutne faze prešla s placeba na duloksetin zabilježeno je suicidalno ponašanje tijekom liječenja duloksetinom u produžetku ispitivanja.
English: Musculoskeletal and connective tissue disorders Musculo-skeletal pain
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva mišićno-koštana bol spazam mišića stezanje mišića trzanje mišića trizmus
English: Treatment of diabetic peripheral neuropathic pain.
Croatian: Liječenje boli kod dijabetičke periferne neuropatije.
English: Treatment with duloxetine showed a statistically significantly greater improvement in GAD symptoms, as measured by PARS severity score for GAD (mean difference between duloxetine and placebo of 2.7 points [95% CI 1.3-4.0]), after 10 weeks of treatment.
Croatian: Pediatric Anxiety Rating Scale, PARS) (srednja vrijednost razlike između duloksetina i placeba iznosila je 2,7 bodova [95% CI 1,3-4,0]) nakon 10 tjedana liječenja.
English: The efficacy of Duloxetine Lilly at the recommended dose of 60 mg once a day was demonstrated in three out of three randomised, double-blind, placebo-controlled, fixed dose acute studies in adult outpatients with major depressive disorder.
Croatian: Djelotvornost lijeka Duloksetin Lilly pri preporučenoj dozi od 60 mg jednom dnevno pokazana je u tri od tri randomizirana, dvostruko slijepa, placebom kontrolirana kratkoročna ispitivanja fiksnih doza u odraslih ambulantno liječenih bolesnika s velikim depresivnim poremećajem.
English: How to take Duloxetine Lilly
Croatian: Kako uzimati Duloksetin Lilly
English: Cases of overdoses, alone or in combination with other medicinal products, with duloxetine doses of 5400 mg were reported.
Croatian: 4.9 Predoziranje Prijavljeni su slučajevi predoziranja duloksetinom, u dozama od 5400 mg, samim ili u kombinaciji s drugim lijekovima.
English: • fainting, dizziness, lightheadedness or fainting on standing up, cold fingers and/or toes
Croatian: • nesvjestica, omaglica, ošamućenost ili nesvjestica pri ustajanju, hladni prsti na rukama i/ili nogama • stezanje u grlu, krvarenje iz nosa
English: Duloxetine Lilly 60 mg once daily demonstrated a statistically significant superiority compared to placebo (p=0.004) on the primary outcome measure, the prevention of depressive relapse, as measured by time to relapse.
Croatian: Duloksetin Lilly u dozi od 60 mg jednom dnevno bio je statistički značajno superiorniji u usporedbi s placebom (p=0,004) s obzirom na primarnu mjeru ishodaprevenciju relapsa depresije, mjereno vremenom do pojave relapsa.
English: Elevated liver enzymes (ALT, AST, alkaline phosphatase) Acute liver injury
Croatian: Poremećaji jetre i žuči hepatitis3 povišene vrijednosti jetrenih enzima (ALT, AST, alkalna fosfataza)
English: Store in the original package to protect from moisture.
Croatian: POSEBNE MJERE ČUVANJA Čuvati u originalnom pakiranju radi zaštite od vlage.
English: Duloxetine Lilly 30 mg is available in packs of 7, 28 and 98 hard gastro-resistant capsules.
Croatian: Duloksetin Lilly 30 mg dostupan je u pakiranjima od 7, 28 i 98 tvrdih želučanootpornih kapsula.
English: No dosage adjustment is necessary for patients with mild or moderate renal dysfunction (creatinine clearance 30 to 80 ml/min).
Croatian: Oštećenje bubrežne funkcije U bolesnika s blagim ili umjerenim poremećajem bubrežne funkcije (klirens kreatinina 30-80 ml/min)
English: Duloxetine was not genotoxic in a standard battery of tests and was not carcinogenic in rats.
Croatian: 5.3 Neklinički podaci o sigurnosti primjene Duloksetin se nije pokazao genotoksičnim u standardnom kompletu testova niti kancerogenim u štakora.
English: Treatment of generalised anxiety disorder.
Croatian: Liječenje generaliziranog anksioznog poremećaja.
English: Duloxetine Lilly is used in adults to treat:
Croatian: Duloksetin Lilly se primjenjuje u odraslih za liječenje: • depresije
English: Multinucleated cells were seen in the liver in the absence of other histopathological changes in the rat carcinogenicity study.
Croatian: Pri ispitivanju kancerogenosti u štakora uočene su multinuklearne stanice u jetri, ali ne i druge histopatološke promjene.
English: Duloxetine Lilly may be associated with sedation and dizziness.
Croatian: Uzimanje lijeka Duloksetin Lilly može biti povezano s pojavom sedacije i omaglice.
English: Stevens-Johnson Syndrome6
Croatian: Stevens-Johnsonov sindrom6 angioneurotski edem6
English: Caution is advisable if Duloxetine Lilly is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John's wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Croatian: Duloksetin Lilly primjenjuje istodobno sa serotoninergičkim lijekovima poput SSRI-ja, SNRI-ja, tricikličkih antidepresiva poput klomipramina i amitriptilina, inhibitora MAO poput moklobemida ili linezolida, gospine trave (Hypericum perforatum) ili triptana, tramadola, petidina i triptofana (vidjeti dio 4.4).
English: Over the entire 36-week course of the study, 6 out of 333 patients initially randomized to duloxetine and 3 out of 225 patients initially randomized to fluoxetine experienced suicidal behaviour (exposure adjusted incidence 0.039 events per patient year for duloxetine and 0.026 for fluoxetine).
Croatian: Tijekom cjelokupnog trajanja ispitivanja od 36 tjedana, suicidalno ponašanje pojavilo se u 6 od 333 bolesnika prvotno randomizirana za primanje duloksetina te u 3 od 225 bolesnika prvotno randomizirana za liječenje fluoksetinom (incidencija prilagođena za izloženost iznosila je
English: Concomitant use of Duloxetine Lilly with nonselective, irreversible monoamine oxidase inhibitors (MAOIs) is contraindicated (see section 4.5).
Croatian: Kontraindicirana je istodobna primjena lijeka Duloksetin Lilly s neselektivnim, ireverzibilnim inhibitorima monoaminooksidaze (MAOI) (vidjeti dio 4.5).
English: 10Estimated frequency based on placebo-controlled clinical trials.
Croatian: 10 Procijenjena učestalost nuspojava prijavljenih tijekom placebom kontroliranih kliničkih ispitivanja.
English: The antibiotic linezolid is a reversible non-selective MAOI and should not be given to patients treated with Duloxetine Lilly (see section 4.4).
Croatian: Antibiotik linezolid je reverzibilan neselektivan MAO inhibitor i ne smije se davati bolesnicima koji se liječe lijekom Duloksetin Lilly
English: Dizziness, sensory disturbances (including paraesthesia or electric shock-like sensations, particularly in the head), sleep disturbances (including insomnia and intense dreams), fatigue, somnolence,
Croatian: Najčešće prijavljene reakcije su omaglica, senzorni poremećaji (uključujući paresteziju ili osjete nalik elektrošoku, osobito u glavi), poremećaji spavanja (uključujući nesanicu i intenzivne snove), umor, somnolencija, agitacija ili anksioznost, mučnina i/ili povraćanje, tremor,
English: Overall, Duloxetine Lilly's efficacy has been demonstrated at daily doses between 60 and 120 mg in a total of five out of seven randomised, double-blind, placebo-controlled, fixed dose acute studies in adult outpatients with major depressive disorder.
Croatian: Sveukupno je djelotvornost lijeka Duloksetin Lilly u dnevnim dozama od 60 do 120 mg pokazana u ukupno pet od sedam randomiziranih, dvostruko slijepih, placebom kontroliranih kratkoročnih ispitivanja fiksnih doza u odraslih ambulantno liječenih bolesnika s velikim depresivnim poremećajem.
English: Weight decrease Weight increase Blood creatine phosphokinase increased
Croatian: Pretrage smanjenje tjelesne težine porast tjelesne težine povišene vrijednosti kreatin fosfokinaze u krvi povišene vrijednosti kalija u krvi povišene vrijednosti kolesterola u krvi
English: Duloxetine Lilly must not be used in patients with liver disease resulting in hepatic impairment (see sections 4.3 and 5.2).
Croatian: Oštećenje jetrene funkcije Duloksetin Lilly se ne smije davati bolesnicima s bolešću jetre čija je posljedica oštećenje jetrene funkcije (vidjeti dijelove 4.3 i 5.2).
English: In a relapse prevention study, patients responding to 12-weeks of acute treatment with open-label Duloxetine Lilly 60 mg once daily were randomised to either Duloxetine Lilly 60 mg once daily or placebo for a further 6-months.
Croatian: U ispitivanju prevencije relapsa, bolesnici koji su reagirali na otvoreno akutno liječenje lijekom Duloksetin Lilly u dozi od 60 mg jednom dnevno u trajanju od 12 tjedana randomizirani su ili u skupinu koja je sljedećih 6 mjeseci uzimala Duloksetin Lilly u dozi od 60 mg jednom dnevno ili u skupinu koja je uzimala placebo.
English: Therefore Duloxetine Lilly should not be administered in combination with potent inhibitors of CYP1A2 like fluvoxamine (see section
Croatian: Lilly ne smije uzimati u kombinaciji s potentnim inhibitorima CYP1A2 poput fluvoksamina (vidjeti dio 4.3).
English: − have severe kidney disease
Croatian: − ako imate tešku bolest bubrega
English: Hyperglycaemia (reported especially in diabetic patients)
Croatian: Poremećaji metabolizma i prehrane smanjen tek hiperglikemija (prijavljena posebno u bolesnika sa šećernom bolešću)
English: Marketing Authorisation Holder: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.
Croatian: NOSITELJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET Eli Lilly Nederland BV Papendorpseweg 83, 3528 BJ Utrecht, Nizozemska
English: Data on the use of Duloxetine Lilly 120 mg in elderly patients with major depressive disorder and generalised anxiety disorder are limited.
Croatian: Starije osobe Postoje samo ograničeni podaci o primjeni lijeka Duloksetin Lilly u dozi od 120 mg u starijih osoba s velikim depresivnim poremećajem i generaliziranim anksioznim poremećajem.
English: Weight increased to match other children and adolescents of their age and sex after 6 months of treatment.
Croatian: Nakon 6 mjeseci liječenja njihova je tjelesna težina porasla i izjednačila se s tjelesnom težinom djece i adolescenata iste dobi i spola.
English: Very rare side effects (may affect up to 1 in 10,000 people)
Croatian: Vrlo rijetke nuspojave (mogu se javiti u najviše 1 na 10 000 osoba)
English: Based on the half-life of duloxetine, at least 5 days should be allowed after stopping Duloxetine Lilly before starting an MAOI (see section
Croatian: mora proći najmanje 5 dana nakon prestanka uzimanja lijeka Duloksetin Lilly prije započinjanja liječenja inhibitorom MAO (vidjeti dio 4.3).
English: Edible green ink contains: Black iron oxide - synthetic (E172) Yellow iron oxide - synthetic (E172) Propylene glycol
Croatian: Jestiva zelena tinta sadrži: željezov oksid, crni - sintetski (E172) željezov oksid, žuti - sintetski (E172) propilenglikol šelak
English: Also, you need to wait at least 5 days after you stop taking Duloxetine Lilly before you take a MAOI.
Croatian: Također, nakon što ste prestali uzimati Duloksetin Lilly, morate pričekati najmanje 5 dana prije nego počnete uzimati inhibitor MAO.
English: Edible green ink: synthetic black iron oxide (E172), synthetic yellow iron oxide (E172), propylene glycol, shellac.
Croatian: Jestiva zelena tinta: sintetski crni željezov oksid (E172), sintetski žuti željezov oksid (E172), propilenglikol, šelak.
English: Duloxetine Lilly hard gastro-resistant capsules contain sucrose.
Croatian: Duloksetin Lilly tvrde želučanootporne kapsule sadrže saharozu.
English: Major Depressive Disorder: Duloxetine Lilly was studied in a clinical programme involving 3,158 patients (1,285 patient-years of exposure) meeting DSM-IV criteria for major depression.
Croatian: 3158 bolesnika (1285 bolesnik-godina izloženosti) koji su zadovoljavali DSM-IV kriterije za veliki depresivni poremećaj.
English: • difficulty or inability to pass urine, difficulty to start urinating, needing to pass urine during the night, needing to pass more urine than normal, having a decreased urine flow
Croatian: • otežano mokrenje ili nemogućnost mokrenja, otežan početak mokrenja, potreba za mokrenjem tijekom noći, pojačana potreba za mokrenjem, smanjen protok mokraće
English: No malformations were observed in another study testing a higher dose of a different salt of duloxetine.
Croatian: U drugom ispitivanju u kojem se ispitivala veća doza druge soli duloksetina nisu uočene malformacije.
English: The concomitant use of Duloxetine Lilly with selective, reversible MAOIs, like moclobemide, is not recommended (see section 4.4).
Croatian: Ne preporučuje se istodobna primjena lijeka Duloksetin Lilly sa selektivnim reverzibilnim inhibitorima MAO, poput moklobemida (vidjeti dio 4.4).
English: A total of 509 paediatric patients aged 7 to 17 years with major depressive disorder and 241 paediatric patients aged 7 to 17 years with generalised anxiety disorder were treated with duloxetine in clinical trials.
Croatian: 17 godina s velikim depresivnim poremećajem i 241 pedijatrijski bolesnik u dobi od 7 do 17 godina s generaliziranim anksioznim poremećajem.
English: Duloxetine is well absorbed after oral administration with a Cmax occurring 6 hours post dose.
Croatian: Duloksetin se nakon peroralne primjene dobro apsorbira, pri čemu se Cmax postiže
English: Consequently, caution is advised when Duloxetine Lilly is taken in combination with other centrally acting medicinal products or substances, including alcohol and sedative medicinal products (e.g. benzodiazepines, morphinomimetics, antipsychotics, phenobarbital, sedative antihistamines).
Croatian: Stoga se preporučuje oprez kada se Duloksetin Lilly primjenjuje u kombinaciji s drugim lijekovima i tvarima koje djeluju na SŽS, uključujući alkohol i sedative (npr. benzodiazepine,
English: • constipation, diarrhoea, stomach pain, being sick (vomiting), heartburn or indigestion, breaking wind
Croatian: • zatvor, proljev, bol u želucu, povraćanje, žgaravica ili loša probava, vjetrovi
English: There was no statistically significant difference in discontinuation due to adverse events between duloxetine and placebo groups during the 10 week acute treatment phase.
Croatian: Tijekom 10-tjedne akutne faze liječenja nije bilo statistički značajne razlike između skupina koje su primale duloksetin odnosno placebo s obzirom na prekid liječenja zbog nuspojava.
English: Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, coma), autonomic instability (e.g., tachycardia, labile blood pressure, hyperthermia), neuromuscular aberrations (e.g. hyperreflexia, incoordination) and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhoea).
Croatian: Simptomi serotoninskog sindroma mogu uključivati promjene mentalnog statusa (npr. agitaciju, halucinacije, komu), nestabilnost autonomnog živčanog sustava (npr. tahikardiju, nestabilan krvni tlak,
English: Protein binding is not affected by renal or hepatic impairment.
Croatian: Oštećenje bubrežne ili jetrene funkcije ne utječe na vezanje za proteine.
English: For patients who experience a sustained increase in blood pressure while receiving duloxetine either dose reduction or gradual discontinuation should be considered (see section 4.8).
Croatian: U bolesnika koji imaju kontinuirano povišenje krvnog tlaka za vrijeme uzimanja duloksetina mora se razmotriti ili smanjivanje doze ili postupan prekid uzimanja lijeka
English: EU/1/14/972/001 (7 hard gastro-resistant capsules) EU/1/14/972/002 (28 hard gastro-resistant capsules) EU/1/14/972/003 (98 hard gastro-resistant capsules)
Croatian: EU/1/14/972/001 (7 tvrdih želučanootpornih kapsula) EU/1/14/972/002 (28 tvrdih želučanootpornih kapsula) EU/1/14/972/003 (98 tvrdih želučanootpornih kapsula)
English: The use of Duloxetine Lilly while breastfeeding is not recommended.
Croatian: Ne preporučuje se uzimanje lijeka Duloksetin Lilly za vrijeme dojenja.
English: Aggression and anger4
Croatian: manija halucinacije agresija i bijes4
English: duloxetine
Croatian: Stoga se Duloksetin
English: 7 hard gastro-resistant capsules 28 hard gastro-resistant capsules 98 hard gastro-resistant capsules
Croatian: 7 tvrdih želučanootpornih kapsula 28 tvrdih želučanootpornih kapsula
English: EU/1/14/972/004 (28 hard gastro-resistant capsules) EU/1/14/972/005 (56 hard gastro-resistant capsules) EU/1/14/972/006 (84 hard gastro-resistant capsules) EU/1/14/972/007 (98 hard gastro-resistant capsules)
Croatian: EU/1/14/972/004 (28 tvrdih želučanootpornih kapsula) EU/1/14/972/005 (56 tvrdih želučanootpornih kapsula) EU/1/14/972/006 (84 tvrde želučanootporne kapsule) EU/1/14/972/007 (98 tvrdih želučanootpornih kapsula)
English: Some fatalities have occurred, primarily with mixed overdoses, but also with duloxetine alone at a dose of approximately 1000 mg. Signs and symptoms of overdose (duloxetine alone or in combination with other medicinal products) included somnolence, coma, serotonin syndrome, seizures, vomiting and tachycardia.
Croatian: Znakovi i simptomi predoziranja (samim duloksetinom ili u kombinaciji s drugim lijekovima) uključivali su somnolenciju, komu, serotoninski sindrom, napadaje, povraćanje i tahikardiju.
English: Edible white ink contains: Titanium dioxide (E171) Propylene glycol Shellac
Croatian: Jestiva bijela tinta sadrži: titanijev dioksid (E171) propilenglikol šelak povidon
English: Pharmacokinetic data on duloxetine is limited in patients with mild or moderate renal impairment.
Croatian: Podaci o farmakokinetici duloksetina u bolesnika s blagim ili umjerenim oštećenjem bubrežne funkcije su ograničeni.
English: In patients responding to duloxetine, and with a history of repeated episodes of major depression, further long-term treatment at a dose of 60 to 120 mg/day could be considered.
Croatian: U bolesnika koji su reagirali na duloksetin, a u anamnezi imaju ponavljajuće epizode velike depresije, može se razmotriti daljnje dugotrajno liječenje dozom od
English: The incidence of relapse during the 6-months double-blind follow-up period was 17% and 29% for duloxetine and placebo, respectively.
Croatian: 6-mjesečnog razdoblja dvostruko slijepog praćenja iznosila je 17% u bolesnika koji su uzimali duloksetin i 29% u onih koji su uzimali placebo.
English: Gynaecological haemorrhage Menstrual disorder Sexual dysfunction Testicular pain
Croatian: Poremećaji reproduktivnog sustava i dojki erektilna disfunkcija poremećaj ejakulacije odgođena ejakulacija ginekološko krvarenje menstrualni poremećaj seksualna disfunkcija bol u testisima simptomi menopauze galaktoreja hiperprolaktinemija
English: Duloxetine has a large volume of distribution and forced diuresis, haemoperfusion, and exchange perfusion are unlikely to be beneficial.
Croatian: hemoperfuzija i izmjena perfuzijom vjerojatno ne bi koristile.
English: What you need to know before you take Duloxetine Lilly DO NOT take Duloxetine Lilly if you:
Croatian: Što morate znati prije nego počnete uzimati Duloksetin Lilly
English: Dista S.A.. Tel: + 34 91 623 17 32
Croatian: Tel: + 34 91 623 17 32
English: Medicines that increase the level of serotonin: Triptans, tramadol, tryptophan, SSRIs (such as paroxetine and fluoxetine), SNRIs (such as venlafaxine), tricyclic antidepressants (such as clomipramine, amitriptyline), pethidine, St John's Wort and MAOIs (such as moclobemide and linezolid).
Croatian: Lijekovi koji povećavaju razinu serotonina: Triptani, tramadol, triptofan, selektivni inhibitori ponovne pohrane serotonina (poput paroksetina i fluoksetina), inhibitori ponovne pohrane serotonina i noradrenalina (poput venlafaksina), triciklički antidepresivi (poput klomipramina, amitriptilina),
English: A free airway should be established.
Croatian: Mora se osigurati prohodnost dišnih putova.
English: • increased blood pressure, flushing
Croatian: • povišen krvni tlak, crvenilo uz osjećaj vrućine